News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

University of Liverpool researchers have secured £2.66m Medical Research Council funding to clinically test a novel immunotherapeutic strategy for non-small cell lung cancer – one of the ...

Relevant protein DNA/RNA processing complexes and their associated mechanisms provide interesting therapeutic targets to researchers, however, due to the complex and often delicate nature of...

Read about our latest case studies, published papers, and upcoming events

Could research which focusses on capturing and characterising “circulating tumour cells” (CTCs) revolutionise the diagnosis and treatment of cancer?

The plasmids have been released at Cobra and are ready to be used as starting material for the GMP batch that will be used in the first clinical study scheduled to begin in 2022.

Bioconjugation

May 4th 2021

TCI presents Bioconjugation reagents to be used for example in drug discovery, ligand binding assays, disease diagnosis and high-throughput screening.

Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project

Encouraging progress is being made towards vaccine development against Covid-19. It is essential that we continue to incentivise and fund research into and development of these technologies.

With direct-to-consumer genetic tests becoming more popular and governments looking to collect and utilise genetic data in clinical and research settings, it appears the amount of genetic da...

Arcis Biotechnology, the nucleic acid sample preparation solution provider, today announced it has signed a commercial distribution agreement with Opentrons, the developer of affordable pip...

ATMP (Advanced therapy medicinal product) specialist Cobra Biologics builds Sweden’s first 500 litre bioreactor investing €20 million at its Matfors facility in Sundsvall.

Agreement gives Iksuda access to Femtogenix’s therapeutic payloads to advance lead ADC for difficult-to-treat solid tumours

Sign up to our Newsletter

Subscribe

* indicates required

Our Valued Sponsors & Partners